Frontlight ResearchEarly access
Kidney cancer trials in United States
210 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT07285044 - Phase 1Not yet taking people in United StatesA Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Basking Ridge, Cleveland, Houston, New Haven, New York, Seattle
- Age
- 18 years and over
- People
- 112 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07848295 - Phase 1/2Taking peopleREGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
- Where
- Duarte, Goodyear, Houston, St Louis, Tampa, Zion
- Age
- 18 years and over
- People
- 265
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07594106 - No phaseTaking peopleDESTINY-PANTUMOUR04
- Where
- Birmingham, Boulder, Bullhead City, Canton, Casa Grande, Coral Springs, Dallas, Decatur, Durham, Farmington, Maumee, Nashville, Philadelphia, San Diego, St. Petersburg, Topeka, West Palm Beach, Wilson
- Age
- 18 years to 130 years
- People
- 100
- Run by
- AstraZeneca
See details and how to joinNCT07124000 - Phase 1Taking peopleA Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
- Where
- Dallas, Houston
- Age
- 18 years and over
- People
- 35
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07401875 - Phase 1Taking peopleCasdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma
- Where
- Nashville
- Age
- 18 years to 100 years
- People
- 12
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT07748988 - Phase 1/2Taking peopleSafety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Where
- Beverly Hills, Boston, Boynton Beach, Dallas, Glendale, Los Angeles, Nashville, Tacoma
- Age
- 18 years and over
- People
- 134
- Run by
- Neonc Technologies, Inc.
See details and how to joinNCT06047379 - Phase 2Taking peopleTrial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
- Where
- Columbus, Indianapolis, La Jolla, New York, St Louis
- Age
- 18 years and over
- People
- 70
- Run by
- Karie Runcie
See details and how to joinNCT06863311 - Phase 2Taking peopleA Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
- Where
- Houston
- Age
- 18 years and over
- People
- 20
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05048212 - Phase 1/2Taking peopleStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Where
- Austin, Grand Rapids, Houston, Huntersville, Miami, Minneapolis, Nashville, Salt Lake City, San Antonio, St Louis
- Age
- 18 years and over
- People
- 159 worldwide
- Run by
- Aulos Bioscience, Inc.
See details and how to joinNCT05267626 - Phase 2Taking peoplePhotodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
- Where
- Detroit
- Age
- 18 years to 75 years
- People
- 10
- Run by
- Henry Ford Health System
See details and how to joinNCT06948552 - Phase 1Taking peopleA Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma
- Where
- Omaha
- Age
- 18 years and over
- People
- 60
- Run by
- PeptiDream Inc.
See details and how to joinNCT07688187 - Phase 2Taking peoplePhotodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA
- Where
- Detroit
- Age
- 18 years to 75 years
- People
- 10
- Run by
- Henry Ford Health System
See details and how to joinNCT07828704 - Phase 2Taking peopleNeoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
- Where
- Dallas
- Age
- 18 years and over
- People
- 30
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT05319015 - Phase 1/2Taking peopleTT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
- Where
- Houston, Los Angeles
- Age
- 18 years and over
- People
- 35
- Run by
- Portage Biotech
See details and how to joinNCT04969315 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Appleton, Aurora, Birmingham, Boston, Broomall, Chandler, Chapel Hill, Cincinnati, Cleveland, Dallas, East Brunswick, Edinburg, Forth Worth, Grand Rapids, Hollywood, Hot Springs, La Jolla, Lakeland, Lewiston, Myrtle Beach, New Orleans, Newport Beach, New York, Philadelphia, Redwood City, Rochester, Rock Hill, Sacramento, Salt Lake City, San Antonio, Shreveport, Toledo, York
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - No phaseTaking peopleBiomarkers of Resiliency In Childhood Cancer Surgery
- Where
- Rochester
- Age
- 3 years to 25 years
- People
- 40
- Run by
- Mayo Clinic
See details and how to joinNCT06674811 - No phaseNot yet taking people in United StatesA Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment
- Where
- Boston
- People
- 30,000
- Run by
- Harvard Medical School (HMS and HSDM)
See details and how to joinNCT07814872 - Phase 1/2Taking peopleSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
- Where
- Charleston, Dallas, East Providence, Grand Rapids, Huntersville, Louisville, San Antonio
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06750185 - Phase 2Taking peopleNeoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
- Where
- Dallas, Philadelphia, Richmond, St Louis
- Age
- 18 years and over
- People
- 69
- Run by
- Qian Qin
See details and how to joinNCT06794229 - Phase 2Taking peopleA Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
- Where
- Chapel Hill, Hershey, Milwaukee, Nashville, Washington D.C.
- Age
- 18 years and over
- People
- 120
- Run by
- Brian Rini
See details and how to joinNCT07188896 - No phaseTaking peoplePatient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
- Where
- Baltimore, Chambersburg
- Age
- 18 years and over
- People
- 90
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06138067 - No phaseTaking peopleA Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 26
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05837767 - Early phase 1Not yet taking people in United StatesEvaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
- Where
- Boston, Grand Rapids, New York
- Age
- 18 years and over
- People
- 40
- Run by
- Lumina Pharmaceuticals Inc
See details and how to joinNCT07781852 - No phaseTaking peopleProject: Every Child for Younger Patients With Cancer
- Where
- Akron, Albany, Albuquerque, Allentown, Amarillo, Anchorage, Ann Arbor, Asheville, Atlanta, Augusta, Aurora, Austin, Baltimore, Bangor, Battle Creek, Bethesda, Bethlehem, Birmingham, Boise, Boston, Brooklyn, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Charlottesville, Chattanooga, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Duarte, Durham, East Lansing, Effingham, El Paso, Falls Church, Fargo, Flint, Fort Lauderdale, Fort Myers, Fort Sam Houston, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Henderson, Hershey, Hollywood, Honolulu, Houston, Huntington, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Kingman, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Loxahatchee Groves, Lubbock, Macon, Madera, Madison, Marshfield, Mattoon, Maywood, McAllen, Memphis, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Muskegon, Nashville, Neptune City, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Niles, Norfolk, Normal, Norton Shores, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Pahrump, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Portsmouth, Providence, Reed City, Reno, Richmond, Roanoke, Rochester, Royal Oak, Sacramento, Saint Joseph, Salt Lake City, San Antonio, San Diego, San Francisco, Santa Barbara, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, Temple, The Bronx, Toledo, Torrance, Traverse City, Tucson, Tulsa, Urbana, Valhalla, Washington D.C., West Palm Beach, Wichita, Wilmington, Winfield, Winston-Salem, Worcester, Wyoming, Yorkville
- Age
- Up to 25 years
- People
- 75,000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT02402244